Neurology
-
Randomized Controlled Trial Multicenter Study
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.
To assess the long-term safety, tolerability, and efficacy of fremanezumab, a fully humanized monoclonal antibody approved for the preventive treatment of migraine. ⋯ This study provides Class IV evidence that long-term fremanezumab treatment is safe, well tolerated, and effective at sustaining reductions in monthly migraine and headache days.